Combined COVID-19-related chronic hypoxemia and lack of screening as a double challenge for the management of asymptomatic invasive lung adenocarcinoma

dc.contributor.authorBouchelaghem, Rim
dc.contributor.authorDjedi, Ahmed Amine
dc.contributor.authorDjedi, Hanène
dc.contributor.authorBoumendjel, Amel
dc.contributor.authorChouabi, Amel
dc.contributor.authorHellal, Nadia
dc.contributor.authorDjendi, Nadia
dc.date.accessioned2025-03-25T07:59:18Z
dc.date.available2025-03-25T07:59:18Z
dc.date.issued2025-03
dc.descriptionThis study was approved by the institutional ethics committee of the Public Hospital Establishment and the Ethics Committee of the Cancer Center of Annaba.
dc.description.abstractIntroduction and aim. Lung adenocarcinoma (LADC) is the most diagnosed histological subtype of lung cancer and the lead ing cause of cancer death in men in Algeria. Defining the circumstances that preceded the diagnosis improves the manage ment options and reduces its incidence. However, data for this critical period are lacking. We report the case of a patient whose onset of severe COVID-19 and the incidental finding of an undefined LADC overlapped and delayed care of the malignancy. Case description. We present the case of a 65-year-old man, with invasive LADC discovered during a chest CT scan performed for suspected severe COVID-19. We describe the diagnostic methods and the patient. Histological examination by biopsy re quired to confirm diagnosis could not be performed due to chronic hypoxemia in the patient, which prevented the complete pathological diagnosis and staging of the disease. Conclusion. Given the prevalence and aggressiveness of LADC in men in Algeria, our study underscores the critical need to develop screening programs, aimed at identifying the disease in asymptomatic patients, in asymptomatic patients that could significantly improve the chances of successful treatment. This is particularly important because LADC patients often develop serious pathologies that can limit their treatment options. COVID-19 serves as a stark example of such limiting interference, further highlighting the importance of early detection in the management of LADC.eng
dc.identifier.citationEuropean Journal of Clinical and Experimental Medicine T. 23, z. 1 (2025), s. 267–276
dc.identifier.doi10.15584/ejcem.2025.1.8
dc.identifier.issn2544-1361
dc.identifier.urihttps://repozytorium.ur.edu.pl/handle/item/11470
dc.language.isoeng
dc.publisherRzeszów University Press
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectchest CT
dc.subjectCOVID-19
dc.subjecthypoxemia
dc.subjectLADC
dc.subjectscreening
dc.titleCombined COVID-19-related chronic hypoxemia and lack of screening as a double challenge for the management of asymptomatic invasive lung adenocarcinoma
dc.typearticle

Pliki

Oryginalny pakiet

Aktualnie wyświetlane 1 - 1 z 1
Ładowanie...
Obrazek miniatury
Nazwa:
31.combined_covid-19-related_chronic_hypoxemia_and_lack_of_screening_as_a_double_challenge_for_the_management_of_asymptomatic_invasive_lung_adenocarcinoma_0.pdf
Rozmiar:
705.59 KB
Format:
Adobe Portable Document Format

Pakiet licencji

Aktualnie wyświetlane 1 - 1 z 1
Nazwa:
license.txt
Rozmiar:
1.28 KB
Format:
Item-specific license agreed upon to submission
Opis: